Medication info
Teragliptin Duo Extended-Release Tablet 10/500 mg

Teragliptin Duo Extended-Release Tablet 10/500 mg

Prescription medicationTabletOral
Ingredient · strength
Teneligliptin Hydrochloride Hydrate›13mg / 1 tabletMetformin Hydrochloride›500mg / 1 tablet
Manufacturer / importer
Palmgen Science Co., Ltd.
Appearance
Orange oval-shaped extended-release film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202201428 · Approved 2022.04.04 · Insurance code 670105310

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal, and the dose should be titrated gradually to reduce gastrointestinal adverse reactions associated with metformin. Take 1 tablet of this medicine 20/1000mg extended-release tablet once daily. Patients taking this medicine 10/750mg or 10/500mg extended-release tablets should take 2 tablets together once daily. For patients whose blood glucose is not adequately controlled with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient's current metformin dose. For patients switching from combination therapy with teneligliptin and metformin to this medicine, treatment may be initiated at the current doses of teneligliptin and metformin. When switching from immediate-release to extended-release metformin, blood glucose control should be closely monitored, and the dose should be adjusted as appropriate. When coadministered with a sulfonylurea, a reduction in the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switching to it from other glucose-lowering medicines. Since this may cause changes in blood glucose control, any change in the treatment of patients with type 2 diabetes should be made under close monitoring. To maintain its extended-release properties, swallow this medicine whole without splitting, crushing, grinding, or chewing it.

Ingredients

Manufacturer
Palmgen Science Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

View approved original text

This medication helps patients with type 2 diabetes to improve blood sugar control. It is primarily used for individuals who are also following dietary and exercise therapy, and it effectively manages blood sugar levels by the combined action of teneligliptin and metformin. This helps stabilize blood sugar levels and contributes to the prevention of complications. Therefore, this medication is used as an adjunct to enhance blood sugar control.

How to take

Adult dose

The dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal, and the dose should be titrated gradually to reduce gastrointestinal adverse reactions associated with metformin. Take 1 tablet of this medicine 20/1000mg extended-release tablet once daily. Patients taking this medicine 10/750mg or 10/500mg extended-release tablets should take 2 tablets together once daily. For patients whose blood glucose is not adequately controlled with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient's current metformin dose. For patients switching from combination therapy with teneligliptin and metformin to this medicine, treatment may be initiated at the current doses of teneligliptin and metformin. When switching from immediate-release to extended-release metformin, blood glucose control should be closely monitored, and the dose should be adjusted as appropriate. When coadministered with a sulfonylurea, a reduction in the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switching to it from other glucose-lowering medicines. Since this may cause changes in blood glucose control, any change in the treatment of patients with type 2 diabetes should be made under close monitoring. To maintain its extended-release properties, swallow this medicine whole without splitting, crushing, grinding, or chewing it.

Precautions

This medication is used for the treatment of diabetes and helps in controlling blood sugar levels. However, there is a rare but serious side effect called lactic acidosis that one should be well aware of. Lactic acidosis is a condition caused by an excessive buildup of lactic acid in the body, which may present symptoms such as muscle pain, weakness, difficulty breathing, and abdominal pain; if any unusual symptoms occur, one should immediately consult a doctor. This medication should not be administered to patients with moderate to severe renal impairment, heart failure, or liver dysfunction. Additionally, if you are undergoing tests using radiopaque agents, this medication should be stopped 48 hours prior to the test and can be resumed only after confirming normal kidney function post-test. It's safest not to use this medication during pregnancy or in women who could become pregnant. The risk of hypoglycemia may increase when used in conjunction with insulin or sulfonylureas, so one should thoroughly understand the symptoms of hypoglycemia and how to manage them. Regular monitoring of kidney function and blood tests is crucial to ensure the safety of this medication while on treatment. Excessive alcohol consumption increases the risk of lactic acidosis, thus alcohol should be avoided. Some patients may experience side effects such as indigestion, constipation, or dizziness; if persistent abdominal pain or vomiting occurs, immediate medical consultation is advised. For patients undergoing surgery, this medication should be discontinued 48 hours before the procedure and can be resumed only after confirming normal kidney function post-surgery. Elderly patients may experience decreased kidney function and thus require dose adjustment and regular monitoring. This medication has not been established for safety in children and should not be used by them. If blisters or rashes appear on the skin while taking this medication, one should inform their doctor immediately. In cases of overdose, immediate medical attention should be sought and blood dialysis may be necessary. This medication should be stored out of reach of children and not transferred to other containers.

Side effects

  • Severe lactic acidosis
  • severe hypoglycemia
  • hypoglycemia
  • constipation
  • intestinal obstruction
  • liver dysfunction
  • interstitial pneumonia
  • bullous pemphigoid
  • acute pancreatitis
  • dizziness
Show 157 more
  • abdominal distension
  • abdominal discomfort
  • nausea
  • abdominal pain
  • bloating
  • stomatitis
  • gastric polyp
  • colonic polyp
  • duodenal ulcer
  • gastroesophageal reflux disease
  • diarrhea
  • loss of appetite
  • elevated amylase
  • elevated lipase
  • elevated AST (GOT)
  • elevated ALT (GPT)
  • elevated GGT
  • elevated ALP
  • proteinuria
  • ketonuria
  • potential hematuria
  • eczema
  • rash
  • itching
  • allergic dermatitis
  • arthralgia
  • elevated CK (CPK)
  • elevated serum potassium levels
  • malaise
  • allergic rhinitis
  • elevated serum uric acid
  • peripheral edema
  • herpes zoster
  • limb pain
  • upper abdominal pain
  • gastritis
  • upper respiratory infection
  • tremors
  • headache
  • weakness
  • hunger
  • fatigue
  • facial edema
  • dyspepsia
  • nausea
  • viral upper respiratory infection
  • rhinitis
  • cold sweat
  • diabetic retinopathy
  • vision loss
  • cough
  • pulmonary congestion
  • dyspnea
  • drug overdose
  • benign prostatic hyperplasia
  • headache
  • diarrhea
  • fatigue
  • cerebral infarction
  • hyperglycemia
  • liver biopsy
  • decreased neutrophils
  • abnormal blood sugar
  • increased blood sugar
  • hepatic coma
  • lumbar spinal canal stenosis
  • spinal disc protrusion
  • spinal disc disorder
  • spinal ligament ossification
  • spinal foraminal stenosis
  • rotator cuff syndrome
  • bladder mass
  • ureterolithiasis
  • urinary stones
  • coronary artery disease
  • unstable angina
  • gastroesophageal reflux disease
  • gastric polyps
  • gastritis
  • bile duct obstruction
  • chronic cholecystitis
  • soft tissue infection
  • pneumonia
  • cataracts
  • depression
  • iliac artery stenosis
  • vertigo
  • benign prostatic hyperplasia
  • knee surgery
  • dizziness
  • diabetic neuropathy
  • paresthesia
  • nasopharyngitis
  • urticaria
  • hepatic coma
  • sensory disturbance
  • sensory reduction
  • tension headache
  • peripheral neuropathy
  • facial paralysis
  • sciatica
  • positional vertigo
  • muscle weakness
  • back pain
  • limb pain
  • tendinitis
  • cervical pain
  • bone pain
  • osteoarthritis
  • osteoporosis
  • muscle cramp
  • foot deformity
  • hypertrophic osteoarthropathy
  • bursitis
  • spinal osteoarthritis
  • postmenopausal osteoporosis
  • chronic gastritis
  • gastritis
  • vomiting
  • upper abdominal pain
  • odynophagia
  • gastrointestinal motility disorder
  • decreased gastrointestinal motility
  • enteritis
  • toothache
  • anal rectal discomfort
  • acquired mixed hyperlipidemia
  • hypertriglyceridemia
  • vitamin D deficiency
  • abnormal weight gain
  • essential hypertension
  • orthostatic hypotension
  • white coat hypertension
  • bleeding
  • increased blood sugar
  • sputum abnormalities
  • toxic hepatitis
  • non-alcoholic fatty liver disease
  • alcoholic liver disease
  • eyelid damage
  • ligament sprain
  • lip injury
  • contusion
  • pressure ulcer
  • glaucoma
  • blurred vision
  • age-related macular degeneration
  • hyperthyroidism
  • hyperparathyroidism
  • otalgia
  • iron deficiency anemia
  • food allergy
  • hearing loss
  • endolymphatic hydrops
  • ovarian cyst
  • vulvar pruritus
  • menopausal symptoms

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air or moisture from entering and it is recommended to store it at room temperature between 1 to 30 degrees Celsius. This way of storage helps maintain the medication’s efficacy and prevent degradation.

Appearance and packaging

Appearance

Orange oval-shaped extended-release film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.